Need professional-grade analysis? Visit stockanalysis.com
$187.90M
N/A
36
N/A
SenzaGen AB (SENZA) trades on Nasdaq Stockholm in SEK. The company is classified in the Healthcare sector under the Diagnostics & Research industry. The stock currently trades at SEK5.40.
Over the past year, SENZA has traded between a low of SEK4.75 and a high of SEK6.60. The stock has gained 12.0% over this period. It is currently 18.2% below its 52-week high.
SenzaGen AB has a market capitalization of $187.90M.
SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also provides biological evaluation, in vitro biocompatibility testing, cytotoxicity, irritation, and skin sensitization medical device services; advisory services for medical devices; and substance based medical devices. In addition, the company offers regulatory toxicity testing services, including skin corrosion, skin irritation, skin sensitization, and skin absorption; and eye irritation, phototoxicity, and genotoxicity testing services. Further, it provides advisory services, such as pharma, medical devices, cosmetics, and chemical. The company offers services through license partners and distributors. It has a collaboration agreement with the Research Institute for Fragrance Materials to develop tests for photosensitization. SenzaGen AB was incorporated in 2010 and is headquartered in Lund, Sweden.
Side-by-side comparison against top Healthcare peers.